Mode VC
Alex Mayweg

Alex Mayweg

Managing Director atVersant VenturesBasel
Full bioFirm profile

Alex Mayweg is a Managing Director at Versant Ventures and head of Ridgeline Therapeutics. He joined in 2016 and has launched and invested in several portfolio companies.

What Alex can write

Writes checks ofNot reported
Comes in atSeed, Series A, Series BCan lead the round
Best routeA warm introAsk a founder in their portfolio.

Career

  1. Roche · global head of chemistry
    prior to 2016
  2. Versant Ventures · Managing Director
    Now
  3. Ridgeline Therapeutics · head

Investments named in public bios

Black Diamond (BDTX)Monte Rosa (GLUE)Bright PeakEnterprise (acquired)T-knifeMatterhornEnterprise

Focus

drug discoverymedicinal chemistrytherapeutics

Education

Oxford University, Ph.D. in organic chemistryStanford University, post-doctorate trainingImperial College in London

Also at Versant Ventures

Brad Bolzon
Brad BolzonChairman & Managing Director
Carlo Rizzuto
Carlo RizzutoManaging Director
Clare Ozawa
Clare OzawaManaging Director
Jerel Davis
Jerel DavisManaging Director
Tom Woiwode
Tom WoiwodeManaging Director
Markus Enzelberger
Markus EnzelbergerPartner
Nigel Sheail
Nigel SheailPartner
Ariel Kantor
Ariel KantorPrincipal

Partners like Alex

At firms with a similar stage, sector and check size.

Ali Tamaseb
Ali TamasebGeneral Partner, DCVC
Jinlin WangPartner, Foothill Ventures
Pete Bastien
Pete BastienPresident & Partner, Hitachi Ventures
Alex Colville
Alex ColvilleCo-Founder and General Partner, The Longevity Fund
Manuel Gonzalez
Manuel GonzalezPartner, AgFunder
Joel S. MarcusExecutive Chairman & Founder; founded and leads Alexandria Venture Investments, Alexandria Venture Investments

Alert me when Versant Ventures is active

One email when Alex's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Alex Mayweg?

Alex Mayweg is a Managing Director at Versant Ventures and head of Ridgeline Therapeutics. He joined in 2016 and has launched and invested in several portfolio companies.

How much does Alex Mayweg invest?

Versant Ventures has not reported a check size. It invests at seed, series a, series b.

How do I pitch Alex Mayweg?

A warm intro from a founder Versant Ventures backed works best.

What did Alex Mayweg do before Versant Ventures?

global head of chemistry at Roche; head at Ridgeline Therapeutics.

Last updated 2026-10-15. Is this you? Ask for a correction.